Physician profile
Blake Ballenger
NPI 1861845539
$5,839.44
in general payments reported to CMS, 2019-2025
8 companies · $444 in 2025
The $444 reported for 2025 was more than what 76% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,569 · 2022: $432 · 2023: $603 · 2024: $1,792 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Food and Beverage: $1,042 · Gift: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Food and Beverage | $1,042.21 |
| Gift | $296.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $5,450.90 | 2021-2025 | |
| Depuy Synthes Sales INC. | $99.69 | 2025 | Na |
| Nobel Biocare USA | $89.85 | 2023 | Nobelactive |
| Envista Holdings Corporation | $69.49 | 2024 | Biomaterials, Creos Xenogain |
| Zimvie INC. | $52.11 | 2022 | |
| Kls-Martin L.P. | $40.50 | 2021-2022 | |
| Ormco Corporation | $25.13 | 2023 | Creos Xenogain |
| Stryker Corporation | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Ballenger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.